USD 0.01
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2022 | - CAD | 0.0% |
2021 | - CAD | 0.0% |
2020 | - CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | -100.0% |
2011 | 280 Thousand CAD | 354.82% |
2010 | 61.56 Thousand CAD | -36.69% |
2009 | 97.23 Thousand CAD | 213.93% |
2008 | 30.97 Thousand CAD | 0.0% |
2007 | - CAD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 Q1 | - CAD | 0.0% |
2023 Q3 | - CAD | 0.0% |
2023 Q2 | - CAD | 0.0% |
2022 Q2 | - CAD | 0.0% |
2022 Q1 | - CAD | 0.0% |
2022 FY | - CAD | 0.0% |
2022 Q4 | - CAD | 0.0% |
2022 Q3 | - CAD | 0.0% |
2021 Q2 | - CAD | 0.0% |
2021 Q3 | - CAD | 0.0% |
2021 Q4 | - CAD | 0.0% |
2021 FY | - CAD | 0.0% |
2021 Q1 | - CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2020 FY | - CAD | 0.0% |
2020 Q4 | - CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2018 Q3 | 1.42 Million CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q4 | - CAD | -100.0% |
2018 Q2 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2012 FY | - CAD | -100.0% |
2012 Q1 | - CAD | -100.0% |
2012 Q4 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2011 Q2 | 253.88 Thousand CAD | 37.46% |
2011 Q1 | 184.69 Thousand CAD | 200.01% |
2011 Q4 | 280 Thousand CAD | 2.16% |
2011 FY | 280 Thousand CAD | 354.82% |
2011 Q3 | 274.07 Thousand CAD | 7.95% |
2010 Q4 | 61.56 Thousand CAD | 21.82% |
2010 Q3 | 50.53 Thousand CAD | 0.0% |
2010 FY | 61.56 Thousand CAD | -36.69% |
2010 Q2 | - CAD | -100.0% |
2010 Q1 | 48.19 Thousand CAD | -50.43% |
2009 Q4 | 97.23 Thousand CAD | 1.98% |
2009 FY | 97.23 Thousand CAD | 213.93% |
2009 Q3 | 95.34 Thousand CAD | 13.99% |
2009 Q2 | 83.64 Thousand CAD | 2.02% |
2009 Q1 | 81.98 Thousand CAD | 164.7% |
2008 Q3 | - CAD | 0.0% |
2008 FY | 30.97 Thousand CAD | 0.0% |
2008 Q4 | 30.97 Thousand CAD | 0.0% |
2007 FY | - CAD | 0.0% |
2007 Q4 | - CAD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
China Medicine Corporation | - USD | NaN% |
DH Enchantment Inc. | - USD | NaN% |
Exlites Holdings International, Inc. | - USD | NaN% |
Itonis, Inc. | - USD | NaN% |
One Step Vending Corp. | - USD | NaN% |
MediPal Holdings Corporation | - USD | NaN% |
PD-Rx Pharmaceuticals, Inc. | - USD | NaN% |
Pharmagen, Inc. | 770.31 USD | 100.0% |
Suzuken Co., Ltd. | - USD | NaN% |